CSID is commonly associated with individuals who are older than 55 years old, have a high mutational burden and contain genetic abnormalities in neurofibromin 1 (NF1), KIT, NRAS, or BRAF non-V600E [16,17]. This evidence concerns the gene NF1 and congenital sucrase-isomaltase deficiency.